O	0	1	A
O	2	7	multi
O	7	8	-
O	8	14	centre
O	15	25	randomised
O	26	31	trial
O	32	41	comparing
B-intervention	42	52	ultrasound
O	53	55	vs
B-control	56	67	mammography
O	68	71	for
O	72	81	screening
O	82	88	breast
O	89	95	cancer
O	96	98	in
O	99	103	high
O	103	104	-
O	104	108	risk
O	109	116	Chinese
O	117	122	women
O	122	123	.

B-ethinicity	124	131	Chinese
O	132	137	women
O	138	142	tend
O	143	145	to
O	146	150	have
O	151	156	small
O	157	160	and
O	161	166	dense
O	167	174	breasts
O	175	178	and
O	179	189	ultrasound
O	190	192	is
O	193	194	a
O	195	201	common
O	202	208	method
O	209	212	for
O	213	219	breast
O	220	226	cancer
O	227	236	screening
O	237	239	in
B-location	240	245	China
O	245	246	.

O	247	254	However
O	254	255	,
O	256	259	its
O	260	268	efficacy
O	269	272	and
O	273	277	cost
O	278	287	comparing
O	288	292	with
O	293	304	mammography
O	305	308	has
O	309	312	not
O	313	317	been
O	318	327	evaluated
O	328	330	in
O	331	341	randomised
O	342	348	trials
O	348	349	.

O	350	352	At
O	353	355	14
O	356	362	breast
O	363	370	centres
O	371	377	across
O	378	383	China
O	384	390	during
O	391	395	2008
O	395	396	-
O	396	400	2010
O	400	401	,
B-total-participants	402	404	13
I-total-participants	405	408	339
B-eligibility	409	413	high
I-eligibility	413	414	-
I-eligibility	414	418	risk
I-eligibility	419	424	women
O	425	429	aged
B-age	430	432	30
I-age	432	433	-
I-age	433	435	65
I-age	436	441	years
O	442	446	were
O	447	457	randomised
O	458	460	to
O	461	463	be
O	464	472	screened
O	473	475	by
O	476	487	mammography
O	488	493	alone
O	493	494	,
O	495	505	ultrasound
O	506	511	alone
O	511	512	,
O	513	515	or
O	516	518	by
O	519	523	both
O	524	531	methods
O	532	534	at
O	535	545	enrollment
O	546	549	and
O	550	551	1
O	551	552	-
O	552	556	year
O	557	563	follow
O	563	564	-
O	564	566	up
O	566	567	.

O	568	569	A
O	570	575	total
O	576	578	of
O	579	581	12
O	582	585	519
O	586	589	and
O	590	594	8692
O	595	600	women
O	601	610	underwent
O	611	614	the
O	615	622	initial
O	623	626	and
O	627	633	second
O	634	644	screenings
O	644	645	,
O	646	658	respectively
O	658	659	.

O	660	665	Among
O	666	669	the
O	670	672	30
B-outcome	673	680	cancers
O	681	682	(
O	682	684	of
O	685	690	which
O	691	693	15
O	694	698	were
O	699	704	stage
O	705	706	0
O	706	707	/
O	707	708	I
O	708	709	)
O	710	718	detected
O	718	719	,
B-cv-bin-abs	720	721	5
O	722	723	(
B-cv-bin-abs	723	724	0
I-cv-bin-abs	724	725	.
I-cv-bin-abs	725	727	72
O	727	728	/
B-control-participants	728	732	1000
O	732	733	)
O	734	738	were
O	739	741	in
O	742	745	the
O	746	757	mammography
O	758	763	group
O	763	764	,
B-iv-bin-abs	765	767	11
O	768	769	(
B-cv-bin-abs	769	770	1
I-cv-bin-abs	770	771	.
I-cv-bin-abs	771	773	51
O	773	774	/
B-intervention-participants	774	778	1000
O	778	779	)
O	780	782	in
O	783	786	the
O	787	797	ultrasound
O	798	803	group
O	803	804	,
O	805	808	and
B-iv-bin-abs	809	811	14
O	812	813	(
B-iv-bin-abs	813	814	2
I-iv-bin-abs	814	815	.
I-iv-bin-abs	815	817	02
O	817	818	/
B-intervention-participants	818	822	1000
O	822	823	)
O	824	826	in
O	827	830	the
O	831	839	combined
O	840	845	group
O	846	847	(
O	847	848	P
O	848	849	=
O	849	850	0
O	850	851	.
O	851	853	12
O	853	854	)
O	854	855	.

O	856	858	In
O	859	862	the
O	863	871	combined
O	872	877	group
O	877	878	,
O	879	889	ultrasound
O	890	898	detected
O	899	902	all
O	903	906	the
B-iv-bin-abs	907	909	14
B-outcome	910	917	cancers
O	917	918	,
O	919	926	whereas
O	927	938	mammography
O	939	947	detected
B-cv-bin-abs	948	949	8
O	949	950	,
O	951	957	making
O	958	968	ultrasound
O	969	973	more
B-outcome	974	983	sensitive
O	984	985	(
B-iv-bin-percent	985	988	100
O	989	991	vs
B-cv-bin-percent	992	994	57
I-cv-bin-percent	994	995	.
I-cv-bin-percent	995	996	1
I-cv-bin-percent	996	997	%
O	997	998	,
O	999	1000	P
O	1000	1001	=
O	1001	1002	0
O	1002	1003	.
O	1003	1005	04
O	1005	1006	)
O	1007	1011	with
O	1012	1013	a
O	1014	1020	better
B-outcome	1021	1031	diagnostic
I-outcome	1032	1040	accuracy
O	1041	1042	(
B-iv-bin-percent	1042	1043	0
I-iv-bin-percent	1043	1044	.
I-iv-bin-percent	1044	1047	999
O	1048	1050	vs
B-cv-bin-percent	1051	1052	0
I-cv-bin-percent	1052	1053	.
I-cv-bin-percent	1053	1056	766
O	1056	1057	,
O	1058	1059	P
O	1059	1060	=
O	1060	1061	0
O	1061	1062	.
O	1062	1064	01
O	1064	1065	)
O	1065	1066	.

O	1067	1072	There
O	1073	1076	was
O	1077	1079	no
O	1080	1090	difference
O	1091	1098	between
O	1099	1110	mammography
O	1111	1114	and
O	1115	1125	ultrasound
O	1126	1128	in
B-outcome	1129	1140	specificity
O	1141	1142	(
B-cv-bin-percent	1142	1145	100
O	1146	1148	vs
B-iv-bin-percent	1149	1151	99
I-iv-bin-percent	1151	1152	.
I-iv-bin-percent	1152	1153	9
I-iv-bin-percent	1153	1154	%
O	1154	1155	,
O	1156	1157	P
O	1157	1158	=
O	1158	1159	0
O	1159	1160	.
O	1160	1162	51
O	1162	1163	)
O	1164	1167	and
B-outcome	1168	1176	positive
I-outcome	1177	1187	predictive
I-outcome	1188	1193	value
O	1194	1195	(
B-cv-bin-percent	1195	1197	72
I-cv-bin-percent	1197	1198	.
I-cv-bin-percent	1198	1199	7
O	1200	1202	vs
B-iv-bin-percent	1203	1205	70
I-iv-bin-percent	1205	1206	.
I-iv-bin-percent	1206	1207	0
I-iv-bin-percent	1207	1208	%
O	1208	1209	;
O	1210	1211	P
O	1211	1212	=
O	1212	1213	0
O	1213	1214	.
O	1214	1216	87
O	1216	1217	)
O	1217	1218	.

O	1219	1221	To
O	1222	1228	detect
O	1229	1232	one
O	1233	1239	cancer
O	1239	1240	,
O	1241	1244	the
B-outcome	1245	1250	costs
O	1251	1253	of
O	1254	1264	ultrasound
O	1264	1265	,
O	1266	1277	mammography
O	1277	1278	,
O	1279	1282	and
O	1283	1291	combined
O	1292	1300	modality
O	1301	1305	were
B-iv-cont-mean	1306	1307	$
I-iv-cont-mean	1307	1311	7876
O	1311	1312	,
B-cv-cont-mean	1313	1314	$
I-cv-cont-mean	1314	1316	45
I-cv-cont-mean	1317	1320	253
O	1320	1321	,
O	1322	1325	and
B-iv-cont-mean	1326	1327	$
I-iv-cont-mean	1327	1329	21
I-iv-cont-mean	1330	1333	599
O	1333	1334	,
O	1335	1347	respectively
O	1347	1348	.

O	1349	1359	Ultrasound
O	1360	1362	is
O	1363	1371	superior
O	1372	1374	to
O	1375	1386	mammography
O	1387	1390	for
O	1391	1397	breast
O	1398	1404	cancer
O	1405	1414	screening
O	1415	1417	in
O	1418	1422	high
O	1422	1423	-
O	1423	1427	risk
O	1428	1435	Chinese
O	1436	1441	women
O	1441	1442	.
